Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort

NCT04345991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Transfusion of COVID-19 convalescent plasma

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]